News & Articles

The digital tool could help simplify the screening, diagnosis and monitoring of patients with respiratory compromise in the current COVID-19 pandemic

The Alinity m molecular laboratory COVID-19 test instrument claims it can run up to 1,080 tests in 24 hours

The U.S. Food and Drug Administration has authorized the first coronavirus test using at-home collection of saliva samples

Partnership to broaden the availability of COVID-19 antibody testing with 100% specificity

The real-time PCR system aims to accelerate coronavirus research and diagnostics

Clinical laboratories certified to perform high complexity tests under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using this ELISA

Register today to reserve a place at the Summit - it opens at 13:00 (BST) / 14:00 (CEST) / 08:00 (EDT) / 05:00 (PDT) on Monday, May 11

AMSBIO's new service utilizes their novel lentiviral system to aid the development of therapeutic drugs and vaccines

The U.S. Food and Drug Administration has approved Tabrecta (capmatinib) to treat adult patients with non-small cell lung cancer

Up to five different fluorescence channels are designed to allow researchers to explore new applications, such as metabolism, with addition of new live-cell ATP and MMP assays

Preliminary results from a government-sponsored study suggest that drug used to treat Ebola may help COVID-19 patients

Innovosens building partnerships to accelerate development, testing and market launch

The blood-based immunoassay test enables clinicians to identify the virus linked with COVID-19

Discover the latest research applications using multiplex technology to maximize sample use, while saving time and money

The serology test promises 100% sensitivity and can help assess patients' immune response to the virus

The molecular test kit promises 100% diagnostic sensitivity and specificity, and is authorized for clinical practice use in Europe

The antibody test, which has a potential time to result of 14 minutes, will join the rest of the company's diagnostic portfolio

The company aims to provide solutions for the pandemic through close collaboration with scientists and providing cutting-edge laboratory equipment

Learn more about how BINDER is helping countless laboratories across the world conduct research into coronavirus.